Literature DB >> 8522529

Superlytic hemolysin mutants of Serratia marcescens.

M Hilger1, V Braun.   

Abstract

Hemolysis by Serratia marcescens is caused by two proteins, ShlA and ShlB. ShlA is the hemolysin proper, and ShlB transports ShlA through the outer membrane, whereby ShlA is converted into a hemolysin. Superhemolytic ShlA derivatives that displayed 7- to 20-fold higher activities than wild-type ShlA were isolated. ShlA80 carried the single amino acid replacement of G to D at position 326 (G326D), ShlA87 carried S386N, and ShlA80III carried G326D and N236D. Superhemolysis was attributed to the greater stability of the mutant ShlA derivatives because they aggregated less than the wild-type hemolysin, which lost activity within 3 min at 20 degrees C. In contrast to the highly hemolytic wild-type ShlA at 0 degrees C, the hyperlytic hemolysins were nonhemolytic at 0 degrees C, suggesting that the hyperlytic derivatives differed from wild-type ShlA in adsorption to and insertion into the erythrocyte membrane. However, the size of the pores formed at 20 degrees C by superhemolytic hemolysins could not be distinguished from that of wild-type ShlA. In addition to the N-terminal sequence up to residue 238, previously identified to be important for activation and secretion, sites 326 and 386 contribute to hemolysin activity since they are contained in regions that participate in hemolysin inactivation through aggregation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8522529      PMCID: PMC177601          DOI: 10.1128/jb.177.24.7202-7209.1995

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  34 in total

1.  Refined structure of the pore-forming domain of colicin A at 2.4 A resolution.

Authors:  M W Parker; J P Postma; F Pattus; A D Tucker; D Tsernoglou
Journal:  J Mol Biol       Date:  1992-04-05       Impact factor: 5.469

2.  In vitro activation of the Serratia marcescens hemolysin through modification and complementation.

Authors:  R Ondraczek; S Hobbie; V Braun
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

Review 3.  Structure and dynamics of the colicin E1 channel.

Authors:  W A Cramer; F S Cohen; A R Merrill; H Y Song
Journal:  Mol Microbiol       Date:  1990-04       Impact factor: 3.501

4.  Hemolysin as a marker for Serratia.

Authors:  Y Ruan; V Braun
Journal:  Arch Microbiol       Date:  1990       Impact factor: 2.552

5.  Cloning and expression in Escherichia coli of the Serratia marcescens metalloprotease gene: secretion of the protease from E. coli in the presence of the Erwinia chrysanthemi protease secretion functions.

Authors:  S Létoffé; P Delepelaire; C Wandersman
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

6.  The HpmA hemolysin is more common than HlyA among Proteus isolates.

Authors:  K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

7.  High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells.

Authors:  J W St Geme; S Falkow; S J Barenkamp
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

8.  Serratia marcescens forms a new type of cytolysin.

Authors:  V Braun; S Hobbie; R Ondraczek
Journal:  FEMS Microbiol Lett       Date:  1992-12-15       Impact factor: 2.742

9.  Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells.

Authors:  E Leininger; M Roberts; J G Kenimer; I G Charles; N Fairweather; P Novotny; M J Brennan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

10.  Structure of the Aeromonas toxin proaerolysin in its water-soluble and membrane-channel states.

Authors:  M W Parker; J T Buckley; J P Postma; A D Tucker; K Leonard; F Pattus; D Tsernoglou
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

View more
  1 in total

1.  Cytotoxic action of Serratia marcescens hemolysin on human epithelial cells.

Authors:  R Hertle; M Hilger; S Weingardt-Kocher; I Walev
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.